Home / Journal
The OncoLegacy Journal.
A student-led monthly journal written by CRS members — twelve issues across Volume I, with Volume II now underway — read by 3,000+ people. Founded 2025 on three pillars: Education, Research, and Impact. Every issue links straight to the full PDF.
Latest · Vol II · Issue II
Drug Conjugates
Hot off the press · Aug 2026
Latest Issue
Drug Conjugates
How antibody–drug conjugates fuse the precision of monoclonal antibodies with potent cytotoxic payloads — delivering chemotherapy directly into cancer cells while sparing healthy tissue, and where the technology is headed next.
The Archive
Explore all thirteen issues.
Each month captures a unique dimension of oncology — from molecular science to the human experience.
Mailing List
Never miss an issue.
Get each new OncoLegacy issue the day it drops — plus early looks at research opportunities and AACR updates.
We email roughly once a month. No spam, unsubscribe anytime.
You're on the list — see you next issue.